MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,300,390 | -66.0% | 1,130,039 | -57.8% | 0.00% | -66.7% |
| Q2 2023 | $33,271,108 | +238.2% | 2,676,678 | +281.2% | 0.01% | +200.0% |
| Q1 2023 | $9,837,976 | +264.8% | 702,211 | +272.7% | 0.00% | +100.0% |
| Q4 2022 | $2,696,448 | -27.7% | 188,431 | +29.0% | 0.00% | 0.0% |
| Q3 2022 | $3,731,000 | -49.2% | 146,116 | -43.5% | 0.00% | -50.0% |
| Q2 2022 | $7,351,000 | +16.3% | 258,751 | +44.3% | 0.00% | +100.0% |
| Q1 2022 | $6,322,000 | -63.1% | 179,253 | -56.1% | 0.00% | – |
| Q4 2021 | $17,120,000 | +84.4% | 408,618 | +116.0% | 0.00% | -100.0% |
| Q3 2021 | $9,286,000 | +155.4% | 189,209 | +117.2% | 0.00% | – |
| Q2 2021 | $3,636,000 | -10.0% | 87,130 | -23.1% | 0.00% | – |
| Q1 2021 | $4,038,000 | -49.7% | 113,299 | -60.4% | 0.00% | -100.0% |
| Q4 2020 | $8,034,000 | – | 286,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |